OptimizeRx to Present at the B. Riley Securities 2021 Vision Day Virtual Conference on January 28, 2021
21 Gennaio 2021 - 1:31PM
OptimizeRx Corp. (Nasdaq: OPRX), a leading provider
of digital health solutions for life science companies, physicians
and patients, has been invited to present at the B. Riley
Securities 2021 Vision Day Conference being held virtually on
January 28, 2021.
OptimizeRx CEO, William Febbo, is scheduled to present on
Thursday, January 28, at 1:30 p.m. Eastern time. The presentation
will be webcast live and available for replay here and via the
investor relations section of the company’s website at
www.optimizerx.com.
Management will discuss how the company’s digital health
communication platform connects life science companies to all
stages of a patient’s care journey, and helps patients afford their
medications and remain on their doctor-recommended course of
treatment.
Management will also discuss the company’s expanding addressable
market due to its launch of new digital health solutions, and how
an increasing number of enterprise-level engagements are keeping
the company on track for another year of record growth.
Register for the conference here. For any questions
about OptimizeRx, please contact Ron Both of CMA at
(949) 432-7557 or submit your request here.
About B. Riley SecuritiesB. Riley Securities is
a full-service investment bank and broker-dealer that provides
corporate finance, sales, trading, and equity research to
institutional clients. For more information about B. Riley,
visit www.brileyfin.com.
About OptimizeRx OptimizeRx is a
digital health company that provides communications solutions for
life science companies, physicians and patients. Connecting over
half of healthcare providers in the U.S. and millions of patients
through a proprietary network, the OptimizeRx digital
health platform helps patients afford and stay on medications. The
platform unlocks new patient and physician touchpoints for life
science companies along the patient journey, from point-of-care, to
retail pharmacy, through mobile patient engagement.
For more information, follow the company on Twitter, LinkedIn or
visit www.optimizerx.com.
Important Cautions Regarding Forward Looking
Statements This press release contains
forward-looking statements within the definition of Section 27A of
the Securities Act of 1933, as amended, and such as in section 21E
of the Securities Act of 1934, as amended. These forward-looking
statements should not be used to make an investment decision. The
words 'estimate,' 'possible' and 'seeking' and similar expressions
identify forward-looking statements, which speak only as to the
date the statement was made. The company undertakes no obligation
to publicly update or revise any forward-looking statements,
whether because of new information, future events, or otherwise.
Forward-looking statements are inherently subject to risks and
uncertainties, some of which cannot be predicted, or quantified.
Future events and actual results could differ materially
from those set forth in, contemplated by, or underlying the
forward-looking statements. The risks and uncertainties to which
forward-looking statements are subject include, but are not limited
to, the effect of government regulation, competition and other
material risks.
OptimizeRx Contact Doug Baker,
CFO Tel (248) 651-6568
(x807) dbaker@optimizerx.com Media
Relations Contact Maira Alejandra, Media
Relations Manager Tel (754)
245-7070 malejandra@optimizerx.com Investor
Relations Contact Ron Both, CMA Tel (949)
432-7557 oprx@cma.team
Grafico Azioni OptimizeRx (NASDAQ:OPRX)
Storico
Da Giu 2024 a Lug 2024
Grafico Azioni OptimizeRx (NASDAQ:OPRX)
Storico
Da Lug 2023 a Lug 2024